The Tullius Lab investigates basic mechanisms with translational significance in transplantation 

We have an expertise and a track record in dissecting novel aspects that shape and impact innate and adaptive immunity related to transplantation. Our goal is to improve and individualize treatment for patients with End-Stage-Organ-Failure. Our approach is based on clinical needs, linking bench-to-bedside.

Our research during the last 10 years has focused on:

- Aspects of immunosenescence and organ age
- Impact of obesity on alloimmunity
- Sex hormone and alloimmune response
- Links between innate and adaptive immunity during aging
- Organ injury and repair
- Specific aspects of rejections subsequent to composite tissue transplantation
- Metabolism and Alloimmunity

STEFAN G. TULLIUS, MD, PHD

Principal Investigator

Joseph E. Murray, MD Distinguished Chair in Transplantation Surgery
Chief, Division of Transplant Surgery,
Director, Transplant Surgery Research Laboratory, Brigham and Women’s Hospital
Professor of Surgery, Harvard Medical School